The CPhI World Pharmaceutical Raw Materials Exhibition was held from October 4-6, 2016 in Barcelona, Spain. As in previous years, Xieli Pharmaceutical participated in this exhibition.

    We had detailed discussions with new customers on product quality, specifications, registration, and other topics regarding the company's two major categories of products: plant-based drugs and anti-tumor drugs. We also had detailed discussions with existing customers on issues that arose during cooperation.

    This year, the company has passed the official audits of PMDA in Japan, EDQM in the European Union, and FDA in the United States. This reflects the company's high-level GMP management and comprehensive quality system, and also lays a solid foundation for the company to expand its business in different countries and regions.